NewAmsterdam Pharma (NAMS) Wins EU Approvals. Can Cholesterol Pills Drive Royalties?

23 9 月, 2026

One Min Read

6 Views

原文: https://finance.yahoo.com/healthcare/articles/newamsterdam-pharma-nams-wins-eu-012024900.html

Last Update: 23 9 月, 2026

Written By

Other Articles

Previous

Interparfums (IPAR) Extends Cavalli Fragrance Deal Through 2046. Can it Boost Profits?

Next

恒指低開22點報25064守兩萬五，資源股偏升，阿里AI發布會翌日低開

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

Prequalified vs. preapproved credit card offers: What’s the difference?

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept